SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Alnylam Pharmaceuticals, Inc. Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$23.30M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +28.61% | 25.90K shares | 10.10M | $200.16 | 116.43K |
| Q2 2022 | share | Increase | +145.53% | 53.66K shares | 7.18M | $145.85 | 90.53K |
| Q1 2022 | share | Decrease | -20.68% | -9.61K shares | -1.93M | $163.29 | 36.87K |
| Q4 2021 | share | Increase | +12.59% | 5.2K shares | 155K | $171.03 | 46.48K |
| Q3 2021 | share | Decrease | -16.86% | -8.37K shares | -623K | $188.81 | 41.28K |
| Q2 2021 | share | Increase | +76.99% | 21.60K shares | 4.45M | $169.52 | 49.66K |
| Q1 2021 | share | Increase | +6.20% | 1.63K shares | 528K | $141.19 | 28.06K |
| Q4 2020 | share | Decrease | -2.66% | -721 shares | -518K | $129.97 | 26.42K |
| Q3 2020 | share | Increase | +20.35% | 4.58K shares | 612K | $145.6 | 27.14K |
| Q2 2020 | share | Increase | +39.39% | 6.37K shares | 1.57M | $148.11 | 22.55K |
| Q1 2020 | share | Decrease | -24.14% | -5.15K shares | -696K | $108.85 | 16.18K |
| Q4 2019 | share | Increase | +29.66% | 4.87K shares | 1.13M | $115.17 | 21.33K |
| Q3 2019 | share | Increase | +25.38% | 3.33K shares | 371K | $80.42 | 16.45K |
| Q2 2019 | share | Decrease | -2.43% | -327 shares | -305K | $72.56 | 13.12K |
| Q1 2019 | share | Increase | +1.42% | 188 shares | 290K | $93.45 | 13.44K |
| Q4 2018 | share | Increase | +9.86% | 1.19K shares | -89K | $72.91 | 13.26K |
| Q3 2018 | share | Increase | +7.10% | 800 shares | -54K | $87.52 | 12.07K |
| Q2 2018 | share | Increase | +6.62% | 700 shares | -149K | $98.49 | 11.27K |
| Q1 2018 | share | Decrease | -35.15% | -5.73K shares | -812K | $119.1 | 10.57K |
| Q4 2017 | share | Increase | 0.00% | 16.3K shares | 2.07M | $127.05 | 16.3K |
| Q4 2016 | share | Decrease | -100.00% | -10.1K shares | -685K | $37.44 | 0 |
| Q3 2016 | share | Increase | 0.00% | 10.1K shares | 685K | $67.78 | 10.1K |
| Q2 2016 | share | Decrease | -100.00% | -9.2K shares | -577K | $55.49 | 0 |
| Q1 2016 | share | 0.00% | 0 shares | -292K | $62.77 | 9.2K |